Requesting a second opinion “Seeking a second opinion is a patient’s right.” Dr Dominique de Valeriola, General Medical Director, Institut Jules Bordet Second opinion Every year, many patients request a second opinion from the multidisciplinary team of the Institut Jules Bordet. ...
Support us Make a donation ...
Breast Cancer Translational Research Laboratory J.C. Heuson Description The aim of the Institut Bordet J.-C. Heuson Breast Cancer Translational Research Laboratory (BCTL) is to facilitate the transfer of scientific discoveries about breast cancer that are made in the laboratory into clinical practice. It seeks to improve the molecular characterisation of breast cancer through the use of leadin...
Making an appointment To make, change or cancel an appointment: Tel : +32 (0)2 541 30 00 from 8.30 a.m. to 12.30 p.m. or from 1.30 p.m. to 5.00 p.m. You can also fill in the online form. Once your request has been received, reception will contact you again on these contact details. Making an appointment Cancel/change an appointment The cancellation or changing of an appointment must be no...
International patients European and non-European patients European patients Documents neededIf you are from a country which is a member of the European Union, it is essential that you bring:Your European Health Insurance Card (EHIC/CEAM) when you go to the hospital, including in the case of an emergency. For a planned hospital stay, you must also bring the S2 form (previously ...
Accessibility and contact How to get to the new Institute? Since the end of November 2021, the Jules Bordet Institute is located on the ULB campus in Anderlecht. All the activities of the Institute take place from now on in Rue Meylemeersch n°90 in 1070 Anderlecht. To get to the new Institute or ...
Teaching at the Institut Jules Bordet “Interns are integrated into an organised, multidisciplinary system under the constant supervision of their intern supervisor and his team.” Prof. Anne-Pascale Meert, Head of the Internal Medicine Clinic and Director of the 2nd and 3rd Master’s Internal Medicine at the Institut Jules Bordet The Institut Jules Bordet, university hospital Our formations ...
Become a volunteer at the Institut Jules Bordet Voluntary work is the free and non-remunerated commitment of persons who act for others or in the collective interest in a framework outside of assistance to family and friends. Voluntary work is not exercised by the same person and for the same organisation in the framework of an employment contract, a service contract or a statutory appointment. Voluntary work at the Jules Bordet Institute We are seeking voluntary workers for various activities, including reception and orientation. If you have some free time and the desire to actively support patients and staff at the Jules Bordet Institute then please contact the coordinator at our voluntary workers secretariat for further information on current n...
Rare tumours “The Institut Jules Bordet has long been recognised for its treatment of rare tumours” Dr Ahmad Awada, Oncologist How we treat rare tumours Rare tumours account for around a quarter of the cancers treated at the Institut Jules Bordet. These cancers require very particular and multidisciplinary treatment. A tumour is described as rare when it affects fewer than 6 people in 100,000. It may appear in an organ or in tissue that is only very rarely affected by cancer (eg: the salivary glands, the penis, etc), or may be situated in an organ where cancer is relatively common but show cell characteristics that are different from those usually observed. ...
Breast cancers “Our patients receive support at every level, including psychological support” Dr Martine Piccart, Medical Oncologist and Scientific Director How we treat breast cancers In Belgium, one woman in eight will develop breast cancer over the course of her life. The Institut Jules Bordet treats around 700 women a year. Our multidisciplinary teams were pioneers in a number of diagnostic and therapeutic approaches to these cancers. ...
Lung and thorax cancers “The therapeutic strategy depends on the type of cancer, its extent and the patient’s general state of health.” Dr Thierry Berghmans, Head of the Thoracic Oncology Clinic How we treat cancers of the lungs and thoracic cavity Thanks to extensive internal and external collaboration, the Institut Bordet is able to treat all cancers of the thoracic cavity, including lung cancer.Several types of cancer can develop in the thorax: small and large cell lung (or “bronchial”) cancer, pulmonary metastases originating in other primary tumours and rare tumours such as cancer of the thymus, mesothelioma, pleura, etc. ...
Prostate cancers “Our aim is to preserve the patient’s quality of life while treating the tumour as effectively as possible.” Dr Alexandre Peltier, Urological surgeon How we treat the prostate cancers Prostate cancer is the most common cancer in men. The Institut Jules Bordet has the cutting-edge technology needed to detect and treat these tumours. ...
Head and neck cancers « Providing comprehensive care for the patient is important for our multidisciplinary team but equally important is providing it without delay ... » Delphine Talmon, Oncological Care Coordinating Nurse (ICSO) How we treat ENT cancers of the head and neck Head and neck cancers include all tumours that develop in the upper aerodigestive tract and ENT (ear, nose and throat) system: tongue, cheek, palate, nose, sinuses, salivary glands, larynx, pharynx, etc. ...
Colorectal cancers “Our philosophy is to care for patients while sparing them any pointless and difficult treatments.” Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet How we treat cancers of the colon or rectum Colorectal cancers are among the most common forms of cancer. Significant advances have been made in improving the way they are treated. Treatment requires a multidisciplinary approach. ...
Thyroid cancers “The therapeutic strategy depends largely on the risk of persistence or recurrence of the disease.” Dr Giuseppe Costante, Endocrinologist and Head of Thyroid Cancer at the EURACAN Project. How we treat thyroid cancers The Institut Jules Bordet treats all types of thyroid cancer. The great majority can be cured but require correct assessment of the risk of recurrence and follow-up care for life. ...
Gynaecological cancers How we treat gynaecological cancers The term gynaecological cancer covers cancers of the endometrium, the ovaries, the cervix, the vulva and the vagina. These intimate cancers require multidisciplinary, personalised care and treatment. Diagnosis – examinations required ...
Bone and soft tissue cancers How we treat bone and soft tissue cancers The medical team at the Institut Jules Bordet treats tumours that appear in the soft tissue (muscles, fat, nerves, blood vessels, etc), primary bone cancer in children (in close collaboration with HUDERF – the Hôpital Universitaire des Enfants Reine Fabiola) and in adults as well as bone metastases. ...
Liver cancers “A surgeon never takes the decision to operate on their own. The management of hepatic tumours is always multidisciplinary.” Dr Vincent Donckier, Hepatobiliary surgeon and head of surgery, Institut Bordet. How we treat liver cancers There are 2 types of hepatic cancer: primary liver cancer and hepatic metastases originating from other primary tumours. Surgery is the major treatment for these cancers but it is limited by the need to conserve sufficient functional liver tissue. Other therapies may be combined with surgery. ...
Urological and male genital cancers “Our patients are supported by a team of medical and paramedical specialists.” Dr Alexandre Peltier, UROLOGICAL SURGEON How we treat male urological and genital cancers Urogenital cancers are tumours that develop in the urinary or genital system. ...
Brain tumours « Neuro-Oncology is above all a multidisciplinary approach at the centre of which the quality of life of the patient is crucial » Dr Philippe Martinive Clinic Director How we treat brain tumours The Institut Jules Bordet treats both primary brain cancers and brain metastases. Medical imaging plays a major role in this treatment because, in the brain, accurate definition of the tumour is crucial. ...